JAZZ PHARMACEUTICALS, INC.

Lobbying client · Pennsylvania · filed 2025 to 2026

Pharmaceutical company.

$130,000 Reported spend

4 Filings counted

1 Firms hired

0 Bills named

Spend is reported income plus in-house expenses across 4 filings. Everything on this page is grouped by the client's LDA id (69994), not by name.

Firms hired 1

THE NICKLES GROUP, LLC $130,000 4 filings

Reported by year 2 years

2026 $100,000 2 filings
2025 $30,000 2 filings

Issues lobbied 3

The count is how many filings named that issue area. A filing reports one lump figure covering every issue on it, so the money above cannot be split between them.

Agencies and chambers lobbied 6

Centers For Medicare and Medicaid Services (CMS) 3
Executive Office of the President (EOP) 3
HOUSE OF REPRESENTATIVES 3
Office of Management & Budget (OMB) 3
SENATE 3
U.S. Trade Representative (USTR) 1

Recent filings 4 total

Q2

THE NICKLES GROUP, LLC

2nd Quarter (Apr 1 - June 30) 2026 · House · Senate · $50,000 income · posted Jul 20, 2026

View → Q1

THE NICKLES GROUP, LLC

1st Quarter (Jan 1 - Mar 31) 2026 · House · Senate · $50,000 income · posted Apr 20, 2026

View → Q4

THE NICKLES GROUP, LLC

4th Quarter (Oct 1 - Dec 31) 2025 · House · Senate · $30,000 income · posted Jan 20, 2026

View → RR

THE NICKLES GROUP, LLC

4th Quarter (Oct 1 - Dec 31) 2025 · posted Dec 1, 2025

View →

Foreign entities disclosed 1

JAZZ PHARMACEUTICALS, PLC Ireland named on 1 filing · highest disclosed ownership 100% · largest disclosed contribution $0

Section 7 of the LD-2: a foreign company or government that owns part of the client, pays toward the lobbying, or benefits from it. Figures are the highest single disclosure across these filings, not a sum: the same stake is re-disclosed each quarter.

Source: federal Lobbying Disclosure Act filings, synced daily. Money is self-reported by the filer and often rounded. Lobbying is legal, disclosed activity.